K. Drejer

In Vitro and In Vivo Potency of Insulin Analogues Designed for Clinical Use

U. Ribel, A. Vølund, J. Schlichtkrull, 1991, Diabetic medicine : a journal of the British Diabetic Association.

Equivalent In Vivo Biological Activity of Insulin Analogues and Human Insulin Despite Different In Vitro Potencies

P. Hougaard, U. Ribel, A. Sorensen, 1990, Diabetes.

Receptor Binding and Tyrosine Kinase Activation by Insulin Analogues With Extreme Affinities Studied in Human Hepatoma HepG2 Cells

S. Gammeltoft, P. Hougaard, K. Drejer, 1991, Diabetes.

Sustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency.

H. Klein, B. Hansen, G. Danielsen, 1996, The Biochemical journal.

Carbohydrate substitution of terminal amino groups: A novel approach to monomeric/dimeric, fast acting non-immunogenic insulin

U. Ribel, S. Havelund, K. H. Jørgensen, 1991 .

The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake.

K. Drejer, 1992, Diabetes/metabolism reviews.

Intranasal Administration of Insulin With Phospholipid as Absorption Enhancer: Pharmacokinetics in Normal Subjects

A. Vaag, K Drejer, A Vaag, 1992, Diabetic medicine : a journal of the British Diabetic Association.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.